| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Revenue | $18.9B | $17.9B | $16.1B | $14.3B | $13.4B | $12.0B | $13.1B | $12.9B |
| Cost of Revenue | — | — | — | — | — | — | — | — |
| Gross Profit | — | — | — | — | — | — | — | — |
| R&D Expense | — | — | — | — | — | — | — | — |
| SG&A Expense | — | — | — | — | — | — | — | — |
| Operating Income | — | — | — | — | — | — | — | — |
| Net Income | $3.6B | $3.4B | $0.4B | $2.6B | $2.8B | $0.2B | $0.5B | $0.5B |
| EPS (Basic) | $36.85 | $33.67 | $3.64 | $22.99 | $23.53 | $1.46 | $3.59 | $3.81 |
| EPS (Diluted) | $36.28 | $33.05 | $3.57 | $22.51 | $23.00 | $1.43 | $3.53 | $3.76 |
| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Total Assets | $190.9B | $181.4B | $175.2B | $158.5B | $176.0B | $165.9B | $151.8B | $137.2B |
| Current Assets | — | — | — | — | — | — | — | — |
| Cash & Equivalents | — | — | — | — | — | — | — | — |
| Total Liabilities | $184.4B | $176.2B | $170.5B | $154.9B | $170.3B | $160.0B | $146.1B | $131.6B |
| Current Liabilities | — | — | — | — | — | — | — | — |
| Stockholders' Equity | $6.5B | $5.2B | $4.7B | $3.6B | $5.7B | $5.9B | $5.7B | — |
| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | $8.3B | $6.6B | $4.7B | $4.4B | $3.3B | $4.6B | $2.3B | $2.6B |
| Investing Cash Flow | $-1.5B | $-0.6B | $-9.3B | $-13.6B | $-4.4B | $-2.9B | $-3.2B | $-0.6B |
| Capital Expenditures | — | — | — | — | — | — | — | — |
| Financing Cash Flow | $-5.2B | $-5.2B | $4.4B | $8.4B | $1.7B | $1.0B | $1.2B | $-1.3B |